This Solicitation opportunity from Department Of Health And Human Services was posted on September 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Implantable Medical-Grade Primary Lithium Batteries
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Solicitation 75F40126Q00420 is a one-time acquisition for the FDA Office of Science and Engineering Laboratories to procure twenty new and unused implantable medical-grade primary lithium batteries with Li/SVO-CFx chemistry. The requirement consists of two distinct configurations of ten units each: a high-rate configuration with a stainless steel case and a medium-rate configuration with a titanium case. These batteries are intended for laboratory-based regulatory science research and will not be implanted in humans or animals. All units within each configuration must originate from the same manufacturing lot and possess a minimum of two years of remaining shelf-life upon delivery. The contract is awarded based on the Lowest Price Technically Acceptable method, with technical acceptability determined on a pass/fail basis against specified salient characteristics. Delivery is required to Silver Spring, Maryland, with the medium-rate configuration due within 30 days and the high-rate configuration within 180 days of award, with a final deadline of March 31, 2028. The contractor must provide battery specifications and safety data sheets and ensure all packaging complies with DOT and IATA Dangerous Goods Regulations. Invoicing is processed electronically through the U.S. Department of Treasury's Invoice Processing Platform System.
General Info
Place of Performance
Silver Spring, MD, 20993, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Implantable Medical-Grade Primary Lithium Batteries — The contractor shall furnish twenty (20) new and unused implantable medical-grade primary lithium batteries of Li/SVO-CFx chemistry, in two configurations of ten (10) units each. No manufacturer, brand, model, or manufacturer part number is specified. Any product meeting every stated salient characteristic is acceptable.
Item 1 — High-rate configuration (Qty 10 EA): Rated capacity 1.70 Ah minimum to 1.90 Ah maximum (nominal 1.78 Ah); OCV-BOL 3.15 V minimum to 3.40 V maximum (nominal 3.25 V); capable of pulse discharge with continuous background load ≥95.3 kΩ, pulse amplitude ≥3.0 A, pulse duration 10 seconds, pulse frequency up to once every 150 days, and 2.0 V cutoff. Stainless steel case; negative case polarity; molybdenum or equivalent terminal; hermetically sealed; weight ≤17 g; volume ≤6.5 cc; approximate dimensions 34.93 mm × 27.94 mm × 6.30 mm and shall not exceed these values by more than 5%; storage temperature –20°C to +60°C. All 10 units shall be from the same manufacturing lot.
Item 2 — Medium-rate configuration (Qty 10 EA): Rated capacity 4.80 Ah minimum to 5.00 Ah maximum (nominal 4.92 Ah); OCV-BOL 3.15 V minimum to 3.40 V maximum (nominal 3.25 V); capable of medium-rate sustained discharge with pulsing, background load 9.53 kΩ, pulse amplitude 20 mA, pulse duration 900 seconds, pulse frequency up to once every 63 days, cutoff voltage 2.0 V minimum, with usable capacity 4.80 Ah to 5.00 Ah between OCV-BOL and cutoff at 37°C. Titanium case; negative case polarity; titanium or equivalent terminal; hermetically sealed; weight ≤22 g; volume ≤12.5 cc; approximate dimensions 46.48 mm × 31.70 mm × 9.63 mm and shall not exceed these values by more than 5%; operating temperature 37°C nominal; storage temperature –20°C to +60°C. All 10 units shall be from the same manufacturing lot.
For both configurations, each battery shall have a minimum of two (2) years remaining from the date of manufacture at delivery. Product documentation shall include battery specifications, safety data sheets (SDS), and other applicable product documentation at no separate charge. Packaging shall follow standard commercial practice and applicable safety and transportation regulations for lithium-based medical-grade components, including applicable DOT and IATA Dangerous Goods Regulations. Lot number and date of manufacture shall be marked on each package. Advance shipping notification shall include carrier, tracking information, and estimated delivery date, and delivery logistics shall be coordinated with the Government POC before shipment. The Government will accept the contractor's standard commercial warranty to the maximum extent practicable. The batteries are passive supply items with no embedded or companion software, no FDA network connection, and no storage or transmission of data. Requirements document is in the solicitation.
More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS